Outcomes | Screening | Screening + HPV vaccination | Incremental value | ICER (ZAR/QALY) |
---|---|---|---|---|
NO DISCOUNTING | ||||
Total costs | ZAR 295 251 951 | ZAR 248 833 762 | ZAR −46 418 189 |  |
Vaccine cost | ZAR 0 | ZAR 183 228 152 | ZAR 183 228 152 | Â |
Screening cost | ZAR 19 794 328 | ZAR 21 262 010 | ZAR 1 467 682 | Â |
CIN1 treatment cost | ZAR 3 641 306 | ZAR 557 658 | ZAR −3 083 648 |  |
CIN2/3 treatment cost | ZAR 3 545 580 | ZAR 561 971 | ZAR −2 983 609 |  |
CC treatment cost | ZAR 268 270 736 | ZAR 43 223 970 | ZAR −225 046 766 |  |
Life years | 3 179 736 | 3 186 707 | 6 971 | Â |
CC cases | 2 161 | 348 | −1 813 |  |
CC cancer deaths | 2 035 | 328 | −1 707 |  |
QALYs | 2 573 677 | 2 580 925 | 7 248 | V + S dominant |
DISCOUNTED AT 5Â % | ||||
Total costs | ZAR 62 169 185 | ZAR 198 527 858 | ZAR 136 358 673 | Â |
Vaccine cost | ZAR 0 | ZAR 183 228 152 | ZAR 183 228 152 | Â |
Screening cost | ZAR 5 766 054 | ZAR 6 223 334 | ZAR 457 279 | Â |
CIN1 treatment cost | ZAR 1 126 206 | ZAR 177 452 | ZAR −948 755 |  |
CIN2/3 treatment cost | ZAR 1 183 601 | ZAR 190 676 | ZAR −992 925 |  |
CC treatment cost | ZAR 54 093 324 | ZAR 8 708 245 | ZAR −45 385 079 |  |
Life years | 1 283 817 | 1 285 076 | 1 259 | Â |
QALYs | 1 039 522 | 1 040 852 | 1 331 | ZAR 102 479 |